Form4insider filings, from the source

Company · CIK 0000882095 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

GILEAD SCIENCES, INC. · GILD

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $16.1M · 13net −$16.1M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 22, 2026 FMForm 4 →Sep 23, 4:17 pm EDTErin BurkhartSVP, Controllership2,991$152.67$117,2511,455—
Sep 15, 2026 SForm 4 →Sep 16, 4:30 pm EDTAndrew D DickinsonChief Financial Officer3,000$145.29$435,870164,096−1.80%10b5-1
Sep 15, 2026 SForm 4 →Sep 16, 4:27 pm EDTJohanna MercierChief Comm & Corp Aff Officer3,000$144.22$432,646116,684−2.51%10b5-1
Sep 10, 2026 FMForm 4 →Sep 11, 6:30 pm EDTAndrew D DickinsonChief Financial Officer4,144$144.81$195,059167,096—
Sep 10, 2026 FMForm 4 →Sep 11, 6:29 pm EDTDietmar BergerChief Medical Officer796$144.81$38,08519,522—
Sep 10, 2026 FMForm 4 →Sep 11, 6:28 pm EDTJohanna MercierChief Comm & Corp Aff Officer4,144$144.81$195,059119,684—
Sep 10, 2026 FMForm 4 →Sep 11, 6:28 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp875$144.81$41,2718,759—
Sep 10, 2026 FMForm 4 →Sep 11, 6:27 pm EDTDaniel Patrick O'DayChairman & CEO, Director13,010$144.81$612,546581,683—
Sep 1, 2026 SForm 4 →Sep 2, 4:12 pm EDTDaniel Patrick O'DayChairman & CEO, Director15,000$148.64$2,229,592577,133−2.53%10b5-1
Aug 26, 2026 SForm 4 →Aug 27, 6:44 pm EDTAnthony WeltersDirector18,000$148.62$2,675,22012,894−58.3%10b5-1
Aug 26, 2026 MForm 4 →Aug 27, 6:44 pm EDTAnthony WeltersDirector18,000$61.06$1,099,05223,176—10b5-1
Aug 20, 2026 SForm 4 →Aug 21, 7:22 pm EDTJeffrey BluestoneDirector5,000$145.02$725,07810,066−33.2%10b5-1
Aug 20, 2026 MForm 4 →Aug 21, 7:22 pm EDTJeffrey BluestoneDirector5,000$67.04$335,20710,401—10b5-1
Aug 17, 2026 SForm 4 →Aug 18, 7:06 pm EDTAndrew D DickinsonChief Financial Officer3,000$138.36$415,080165,646−1.78%10b5-1
Aug 17, 2026 SForm 4 →Aug 18, 6:54 pm EDTJohanna MercierChief Comm & Corp Aff Officer28,000$137.64$3,853,908118,234−19.1%10b5-1
Aug 17, 2026 MForm 4 →Aug 18, 6:54 pm EDTJohanna MercierChief Comm & Corp Aff Officer25,000$67.07$1,676,773146,234—10b5-1
Aug 10, 2026 FMForm 4 →Aug 11, 4:51 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp8,910$133.06$386,9388,454—
Aug 3, 2026 SForm 4 →Aug 4, 5:40 pm EDTDaniel Patrick O'DayChairman & CEO, Director15,000$130.31$1,954,694592,133−2.47%10b5-1
Jul 15, 2026 SForm 4 →Jul 16, 6:08 pm EDTAndrew D DickinsonChief Financial Officer3,000$129.93$389,777168,646−1.75%10b5-1
Jul 15, 2026 SForm 4 →Jul 16, 4:54 pm EDTJohanna MercierChief Comm & Corp Aff Officer3,000$129.92$389,758121,234−2.41%10b5-1
Jul 1, 2026 SForm 4 →Jul 2, 4:14 pm EDTDaniel Patrick O'DayChairman & CEO, Director15,000$126.29$1,894,400607,133−2.41%10b5-1
Jun 15, 2026 SForm 4 →Jun 16, 6:02 pm EDTJohanna MercierChief Comm & Corp Aff Officer3,000$123.92$371,762124,234−2.36%10b5-1
Jun 15, 2026 SForm 4 →Jun 16, 5:53 pm EDTAndrew D DickinsonChief Financial Officer3,000$125.40$376,200171,646−1.72%10b5-1
Jun 10, 2026 FMForm 4 →Jun 11, 6:35 pm EDTDietmar BergerChief Medical Officer796$121.48$31,94919,252—
Jun 10, 2026 FMForm 4 →Jun 11, 6:34 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp872$121.48$34,3795,360—
Jun 10, 2026 FMForm 4 →Jun 11, 6:32 pm EDTAndrew D DickinsonChief Financial Officer4,137$121.48$162,905174,646—
Jun 10, 2026 FMForm 4 →Jun 11, 6:31 pm EDTJohanna MercierChief Comm & Corp Aff Officer4,137$121.48$162,905127,234—
Jun 10, 2026 FMForm 4 →Jun 11, 6:29 pm EDTDaniel Patrick O'DayChairman & CEO, Director12,992$121.48$511,795622,133—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 22, 2026 MForm 4 →Sep 23, 4:17 pm EDTErin BurkhartSVP, Controllership2,223——9,022—
Sep 10, 2026 MForm 4 →Sep 11, 6:30 pm EDTAndrew D DickinsonChief Financial Officer2,797——25,054—
Sep 10, 2026 MForm 4 →Sep 11, 6:29 pm EDTDietmar BergerChief Medical Officer533——46,395—
Sep 10, 2026 MForm 4 →Sep 11, 6:28 pm EDTJohanna MercierChief Comm & Corp Aff Officer2,797——25,054—
Sep 10, 2026 MForm 4 →Sep 11, 6:28 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp590——13,405—
Sep 10, 2026 MForm 4 →Sep 11, 6:27 pm EDTDaniel Patrick O'DayChairman & CEO, Director8,780——83,300—
Aug 26, 2026 MForm 4 →Aug 27, 6:44 pm EDTAnthony WeltersDirector18,000——5,569—10b5-1
Aug 20, 2026 MForm 4 →Aug 21, 7:22 pm EDTJeffrey BluestoneDirector5,000——11,395—10b5-1
Aug 17, 2026 MForm 4 →Aug 18, 6:54 pm EDTJohanna MercierChief Comm & Corp Aff Officer25,000——69,960—10b5-1
Aug 10, 2026 MForm 4 →Aug 11, 4:51 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp6,002——13,995—
Jun 10, 2026 MForm 4 →Jun 11, 6:35 pm EDTDietmar BergerChief Medical Officer533——46,928—
Jun 10, 2026 MForm 4 →Jun 11, 6:34 pm EDTWettan Keeley M CainEVP Gen Counsel, Legal & Comp589——19,997—
Jun 10, 2026 MForm 4 →Jun 11, 6:32 pm EDTAndrew D DickinsonChief Financial Officer2,796——27,851—
Jun 10, 2026 MForm 4 →Jun 11, 6:31 pm EDTJohanna MercierChief Comm & Corp Aff Officer2,796——27,851—
Jun 10, 2026 MForm 4 →Jun 11, 6:29 pm EDTDaniel Patrick O'DayChairman & CEO, Director8,779——92,080—